Studies on metal–organic framework (MOF) nanomedicine preparations of sildenafil for the future treatment of pulmonary arterial hypertension

Abstract Pulmonary arterial hypertension (PAH) is an incurable disease, although symptoms are treated with a range of dilator drugs. Despite their clinical benefits, these drugs are limited by systemic side-effects. It is, therefore, increasingly recognised that using controlled drug-release nanofor...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Nura A. Mohamed, Haissam Abou-Saleh, Yu Kameno, Isra Marei, Gilberto de Nucci, Blerina Ahmetaj-Shala, Fisnik Shala, Nicholas S. Kirkby, Lewis Jennings, Dana E. Al-Ansari, Robert P. Davies, Paul D. Lickiss, Jane A. Mitchell
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/8e7b211a296b4ff6ae224dc791158fee
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!